GOOD NEWS FOR BOWELS
An FDA advisory panel last week recommended approval for a new drug, infliximab, to treat Crohn's disease--a painful, chronic inflammation of the gastrointestinal tract. There's no cure for Crohn's, but infliximab, which is administered intravenously, significantly reduces symptoms--sometimes for months at a time. Final approval is expected by this fall.
BAD NEWS FOR DRIVERS
Car smell like an old pair of running shoes? The problem may lie in your air conditioner. A new report finds that about 3% of autos--high- and low-end models--have fungi and bacteria breeding in the moisture that collects on the a.c. It won't...